Next Article in Journal
Research Updates for Influenza Virus and Vaccine Development
Next Article in Special Issue
Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism
Previous Article in Journal
Comparative Analysis of the Productivity and Immunogenicity of an Attenuated Classical Swine Fever Vaccine (LOM) and an Attenuated Live Marker Classical Swine Fever Vaccine (Flc-LOM-BErns) from Laboratory to Pig Farm
Previous Article in Special Issue
Model Comparisons of the Cost Effectiveness of Rubella Vaccination Method in Japanese Adults
Article

The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland

1
Department of Environmental Medicine, Poznań University of Medical Sciences, 60-806 Poznań, Poland
2
Integrated Science Association (ISA), Universal Scientific Education and Research Network (USERN), 60-806 Poznań, Poland
3
Department of Biochemistry and Biotechnology, Poznań University of Life Sciences, 60-632 Poznań, Poland
4
Department of Preventive Medicine, Poznań University of Medical Sciences, 60-179 Poznań, Poland
*
Author to whom correspondence should be addressed.
Academic Editor: Paolo Bonanni
Vaccines 2021, 9(4), 382; https://doi.org/10.3390/vaccines9040382
Received: 17 March 2021 / Revised: 7 April 2021 / Accepted: 13 April 2021 / Published: 14 April 2021
Vaccine hesitancy is a major threat to the success of COVID-19 vaccination programs. The present cross-sectional online survey of adult Poles (n = 1020) expressing a willingness to receive the COVID-19 vaccine was conducted between February and March 2021 and aimed to assess (i) the general trust in different types of vaccines, (ii) the level of acceptance of the COVID-19 vaccines already in use in Poland (BNT162b2 by BioNTech/Pfizer, mRNA-1273 by Moderna and AZD1222 by Oxford/AstraZeneca) as well as eight vaccines approved outside European Union (EU) or in advanced stages of clinical trials, (iii) level of fear of vaccination against COVID-19, and (iv) main sources of information on COVID-19 vaccination. Among all major vaccine technology, the highest level of trust was observed for the mRNA platform, with a considerable number of surveyed (>20%) not aware of the existence of vaccines produced using the traditional approach (inactivated and live attenuated vaccines). The age of participants was the main factor differentiating the level of trust in a particular vaccine type. Both BNT162b and mRNA-1273 received a high level of acceptance, contrary to AZD1222. From eight vaccines unauthorized in the EU at the moment of study, the CVnCoV (mRNA; CureVac) was met with the highest level of trust, followed by Ad26.COV2.S (vector; Janssen/Johnson&Johnson) and NVX-CoV2373 (protein; Novavax). Sputnik V (vector; Gamaleya Research Institute) was decidedly the least trusted vaccine. The median level of fear (measured by the 10-point Likert-type scale) in the studied group was 4.0, mostly related to the risk of serious allergic reactions, other severe adverse events and unknown long-term effects of vaccination. Female, individuals with a lower level of education and those not seeking any information on the COVID-19 vaccines revealed a higher fear of vaccination. Experts’ materials were the major source of information on COVID-19 vaccines in the studied group. The study shows the level of trust in COVID-19 vaccines can vary much across the producers while the mRNA vaccines are received with a high level of acceptance. It also emphasizes the need for effective and continuous science communication when fighting the pandemic as it may be an ideal time to increase the general awareness of vaccines. View Full-Text
Keywords: COVID-19; vaccinations; vaccine hesitancy; mRNA vaccines; vector vaccines; SARS-CoV-2 COVID-19; vaccinations; vaccine hesitancy; mRNA vaccines; vector vaccines; SARS-CoV-2
Show Figures

Figure 1

MDPI and ACS Style

Rzymski, P.; Zeyland, J.; Poniedziałek, B.; Małecka, I.; Wysocki, J. The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland. Vaccines 2021, 9, 382. https://doi.org/10.3390/vaccines9040382

AMA Style

Rzymski P, Zeyland J, Poniedziałek B, Małecka I, Wysocki J. The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland. Vaccines. 2021; 9(4):382. https://doi.org/10.3390/vaccines9040382

Chicago/Turabian Style

Rzymski, Piotr; Zeyland, Joanna; Poniedziałek, Barbara; Małecka, Ilona; Wysocki, Jacek. 2021. "The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland" Vaccines 9, no. 4: 382. https://doi.org/10.3390/vaccines9040382

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop